Liver cirrhosis treatment market is estimated to reach approximately $15 billion in the U.S. by 2030 Ramat Gan, Israel, Feb.

Can-Fite BioPharma (CANF) announced a significant clinical development: the disappearance of episodes of decompensated liver cirrhosis ...

According to the NHS website, most liver diseases do not cause any symptoms in the early stages. Once you start to get ...

A gastroenterologist has revealed a number of changes to your skin that could indicate underlying liver disease. Dr Saurabh ...

A doctor has shared four changes to your skin that could be a sign of liver problems. Gastroenterologist Dr Saurabh Sethi, ...

Hepatitis C treatment has undergone a remarkable transformation New antiviral medications offer shorter more effective ...

Oral vancomycin therapy resulted in clinical response in nearly half of patients with inflammatory bowel disease associated ...

Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...

Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...

Dr. Sarah Chen, chief hepatologist at Metropolitan Liver Center, explains that the liver communicates distress through subtle ...

Symptoms that are sometimes diagnosed as part of dementia might actually be related to a treatable liver condition, according ...

Discover why combining simvastatin and rifaximin does not offer a clinically meaningful advantage in preventing severe ...